skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Treatment Outcome remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Material Type:
Artigo
Adicionar ao Meu Espaço

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Robson, Mark ; Im, Seock-Ah ; Senkus, Elżbieta ; Xu, Binghe ; Domchek, Susan M ; Masuda, Norikazu ; Delaloge, Suzette ; Li, Wei ; Tung, Nadine ; Armstrong, Anne ; Wu, Wenting ; Goessl, Carsten ; Runswick, Sarah ; Conte, Pierfranco

The New England journal of medicine, 2017-08, Vol.377 (6), p.523-533 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

2
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Soria, Jean-Charles ; Ohe, Yuichiro ; Vansteenkiste, Johan ; Reungwetwattana, Thanyanan ; Chewaskulyong, Busyamas ; Lee, Ki Hyeong ; Dechaphunkul, Arunee ; Imamura, Fumio ; Nogami, Naoyuki ; Kurata, Takayasu ; Okamoto, Isamu ; Zhou, Caicun ; Cho, Byoung Chul ; Cheng, Ying ; Cho, Eun Kyung ; Voon, Pei Jye ; Planchard, David ; Su, Wu-Chou ; Gray, Jhanelle E ; Lee, Siow-Ming ; Hodge, Rachel ; Marotti, Marcelo ; Rukazenkov, Yuri ; Ramalingam, Suresh S

The New England journal of medicine, 2018-01, Vol.378 (2), p.113-125 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

3
Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation
Material Type:
Artigo
Adicionar ao Meu Espaço

Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation

Kaufman, Bella ; Shapira-Frommer, Ronnie ; Schmutzler, Rita K ; Audeh, M William ; Friedlander, Michael ; Balmaña, Judith ; Mitchell, Gillian ; Fried, Georgeta ; Stemmer, Salomon M ; Hubert, Ayala ; Rosengarten, Ora ; Steiner, Mariana ; Loman, Niklas ; Bowen, Karin ; Fielding, Anitra ; Domchek, Susan M

Journal of clinical oncology, 2015-01, Vol.33 (3), p.244-250 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

4
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Material Type:
Artigo
Adicionar ao Meu Espaço

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

Mauri, Laura ; Kereiakes, Dean J ; Yeh, Robert W ; Driscoll-Shempp, Priscilla ; Cutlip, Donald E ; Steg, P. Gabriel ; Normand, Sharon-Lise T ; Braunwald, Eugene ; Wiviott, Stephen D ; Cohen, David J ; Holmes, David R ; Krucoff, Mitchell W ; Hermiller, James ; Dauerman, Harold L ; Simon, Daniel I ; Kandzari, David E ; Garratt, Kirk N ; Lee, David P ; Pow, Thomas K ; Ver Lee, Peter ; Rinaldi, Michael J ; Massaro, Joseph M

The New England journal of medicine, 2014-12, Vol.371 (23), p.2155-2166 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

5
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
Material Type:
Artigo
Adicionar ao Meu Espaço

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component

Yang, James Chih-Hsin ; Ahn, Myung-Ju ; Kim, Dong-Wan ; Ramalingam, Suresh S ; Sequist, Lecia V ; Su, Wu-Chou ; Kim, Sang-We ; Kim, Joo-Hang ; Planchard, David ; Felip, Enriqueta ; Blackhall, Fiona ; Haggstrom, Daniel ; Yoh, Kiyotaka ; Novello, Silvia ; Gold, Kathryn ; Hirashima, Tomonori ; Lin, Chia-Chi ; Mann, Helen ; Cantarini, Mireille ; Ghiorghiu, Serban ; Jänne, Pasi A

Journal of clinical oncology, 2017-04, Vol.35 (12), p.1288-1296 [Periódico revisado por pares]

United States

Texto completo disponível

6
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment
Material Type:
Artigo
Adicionar ao Meu Espaço

CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment

DeMichele, Angela ; Clark, Amy S ; Tan, Kay See ; Heitjan, Daniel F ; Gramlich, Kristi ; Gallagher, Maryann ; Lal, Priti ; Feldman, Michael ; Zhang, Paul ; Colameco, Christopher ; Lewis, David ; Langer, Melissa ; Goodman, Noah ; Domchek, Susan ; Gogineni, Keerthi ; Rosen, Mark ; Fox, Kevin ; O'Dwyer, Peter

Clinical cancer research, 2015-03, Vol.21 (5), p.995-1001 [Periódico revisado por pares]

United States

Texto completo disponível

7
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
Material Type:
Artigo
Adicionar ao Meu Espaço

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

Ross, David M. ; Branford, Susan ; Seymour, John F. ; Schwarer, Anthony P. ; Arthur, Christopher ; Yeung, David T. ; Dang, Phuong ; Goyne, Jarrad M. ; Slader, Cassandra ; Filshie, Robin J. ; Mills, Anthony K. ; Melo, Junia V. ; White, Deborah L. ; Grigg, Andrew P. ; Hughes, Timothy P.

Blood, 2013-07, Vol.122 (4), p.515-522 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

8
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up
Material Type:
Artigo
Adicionar ao Meu Espaço

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Rugo, H. S. ; Finn, R. S. ; Diéras, V. ; Ettl, J. ; Lipatov, O. ; Joy, A. A. ; Harbeck, N. ; Castrellon, A. ; Iyer, S. ; Lu, D. R. ; Mori, A. ; Gauthier, E. R. ; Bartlett, C. Huang ; Gelmon, K. A. ; Slamon, D. J.

Breast cancer research and treatment, 2019-04, Vol.174 (3), p.719-729 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

9
Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

Oza, Amit M, Prof ; Cibula, David, Prof ; Benzaquen, Ana Oaknin, MD ; Poole, Christopher, Prof ; Mathijssen, Ron H J, Prof ; Sonke, Gabe S, MD ; Colombo, Nicoletta, MD ; Špaček, Jiří, MD ; Vuylsteke, Peter, MD ; Hirte, Holger, MD ; Mahner, Sven, MD ; Plante, Marie, MD ; Schmalfeldt, Barbara, Prof ; Mackay, Helen, MD ; Rowbottom, Jacqui, PhD ; Lowe, Elizabeth S, MD ; Dougherty, Brian, PhD ; Barrett, J Carl, PhD ; Friedlander, Michael, Prof

The lancet oncology, 2015, Vol.16 (1), p.87-97 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

10
A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers
Material Type:
Artigo
Adicionar ao Meu Espaço

A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers

Paik, Paul K ; Shen, Ronglai ; Berger, Michael F ; Ferry, David ; Soria, Jean-Charles ; Mathewson, Alastair ; Rooney, Claire ; Smith, Neil R ; Cullberg, Marie ; Kilgour, Elaine ; Landers, Donal ; Frewer, Paul ; Brooks, Nigel ; André, Fabrice

Clinical cancer research, 2017-09, Vol.23 (18), p.5366-5373 [Periódico revisado por pares]

United States: American Association for Cancer Research Inc

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.258)

Data de Publicação 

De até
  1. Antes de2000  (28)
  2. 2000Até2005  (258)
  3. 2006Até2011  (536)
  4. 2012Até2018  (407)
  5. Após 2018  (84)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.285)
  2. Japonês  (127)
  3. Alemão  (11)
  4. Português  (6)
  5. Francês  (5)
  6. Espanhol  (5)
  7. Russo  (2)
  8. Sueco  (2)
  9. Norueguês  (2)
  10. Chinês  (2)
  11. Polonês  (1)
  12. Dinamarquês  (1)
  13. Holandês  (1)
  14. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.